Skip to main content
Log in

Acid-stable protease inhibitor in chronic phase of carrageenin-induced inflammation in rats

  • Original Articles
  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

The activity and kinetics of acid-stable protease inhibitor (ASPI) were investigated in the chroric phase of carrageenin-induced inflammation in rats. The ASPI activity was 19.6+3.1 units/ml in the plasma and 15.4+2.1 units/ml in the inflammatory exudate. The plasma value was significantly higher than that of the control (11.6+1.3 units/ml). A kinetics study was performed using purified and radiolabeled rat plasma ASPI, whose NH2-terminal amino acid sequence was Ala-Val-Leu-Pro-Gln-Glu-Asn-Glu-Gly-X-Gly-Ser-Glu-Pro-Leu-Ile-Thr-Gly-Thr-Leu-Lys-Lys-Glu-Asp-Ser-Asn-Gln-Leu-Lys-Tyr-Ser-Glu-Gly-Pro. The half-life of the distributive phase was 4.3+0.4 min and that of the postdistributive phase (biological half-life) was 42.2+9.2 min in inflammation. There was no significant difference compared with the values in the control (3.9+0.4 min and 40.7+6.5 min, respectively). It appeared that the increase in ASPI in inflammation was not due to prolonged excretion of the inhibitor but to an increased production of it, and ASPI was rapidly distributed to the fluids and tissues.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Balduyck, M., C. Mizon, H. Ioutfi, C. Richet, P. Roussel, andJ. Mizon. 1986. The major human urinary trypsin inhibitor is a proteoglycan.Eur. J. Biochem. 158:417–422.

    Google Scholar 

  2. Gosset, D., C. Mizon, P. Savinel, M. Balduyck, B. Boniface, P. Y. Hatron, J. Mizon, andB. Devulder. 1988. Clinical value of the determination of urinary antitrypsin activity.Presse Med. 17:329–332.

    Google Scholar 

  3. Toki, N., andH. Sumi. 1982. Urinary trypsin inhibitor and urokinase activities in renal diseases.Acta Haematol. 67:109–113.

    Google Scholar 

  4. Gebhard, W., andK. Hochstrasser. 1986. Inter-α-trypsin inhibitor and its close relatives.In Proteinase Inhibitors. A. J. Barrett, and G. Salvesen, editors. Eisevier Science Publishers, Amsterdam. 389–401.

    Google Scholar 

  5. Shikimi, T., andM. Handa. 1986. Inhibitory effect of human urinary trypsin inhibitor (urinastatin) on lysosomal thiol proteinases.Jpn. J. Pharmacol. 42:571–574.

    Google Scholar 

  6. Kikuchi, H., S. Tanaka, andO. Matsuo. 1987. Plasminogen activator on synovial fluid from patients with rheumatoid arthritis.J. Rheumatol. 14:439–445.

    Google Scholar 

  7. Matsuo, O., S. Tanaka, andH. Kikuchi. 1988. Effect of urinary trypsin inhibitor on osteoarthritis.Thromb. Res. 52:237–245.

    Google Scholar 

  8. Maruyama, M., H. Sumi, K. Akazawa, andH. Mihara. 1984. Marked increase of plasma acid stable/soluble trypsin inhibitor in hemodialysis patients.Clin. Chim. Acta 138:205–213.

    Google Scholar 

  9. Akazawa, K., H. Sumi, M. Maruyama, andH. Mihara. 1983. Acid stable protease inhibitor in ascites of ovarian carcinoma.Clin. Chim. Acta 131:87–99.

    Google Scholar 

  10. Yamamoto, T., H. Sumi, M. Maruyama, H. Mizumoto, R. Ikeda, H. Yoshihara, andH. Mihara. 1986. Acid stable trypsin inhibitor in bile.Clin. Chim. Acta 158:91–98.

    Google Scholar 

  11. Okumichi, T., M. Nishiki, S. Takasugi, N. Toki, andH. Ezaki. 1984. Isolation of urinary trypsin inhibitor-like inhibitor from human lung cancer tissue.Cancer Res. 44:2011–2015.

    Google Scholar 

  12. Sugiki, M., H. Sumi, M. Maruyama, E. Yoshida, andH. Mihara. 1989. Clearance and distribution of acid-stable trypsin inhibitor (ASTI).Enzyme 42:31–38.

    Google Scholar 

  13. Hochstrasser, K., J. Niebel, H. Feuth, andK. Lempart. 1977. Über Abbauprodukte des Inter-alpha-Trypsininhibitors im Serum. I. Der Inter-alpha-Trypsininhibitor als Prekursor des säurestabilen Serum-Trypsin-Plasmin-Inhibitors.Klin. Wochenschr. 55:337–342.

    Google Scholar 

  14. Franck, C., andJ. Z. Pedersen. 1983. Trypsin-inhibitory activities of acid-stable fragments of the inter-alpha-trypsin inhibitor in inflammatory and uraemic conditions.Scand. J. Lab. Invest. 43:151–155.

    Google Scholar 

  15. Sumi, H., E. Yoshida, H. Hamada, andH. Mihara. 1988. Acid-stable trypsin-plasmin inhibitors formed enzymatically from plasma precursor protein.Biochim. Biophys. Acta 966:1–11.

    Google Scholar 

  16. Salier, J. P., R. Sesboue, K. Hochstrasser, O. Schonberger, andJ. P. Martin. 1983. Isolation and characterization of an inter-α-trypsin inhibitor-IgG complex from human serum.Biochim. Biophys. Acta 742:206–214.

    Google Scholar 

  17. McKeehan, W. L., Y. Sakagami, H. Hoshi, andK. A. McKeehan. 1986. Two apparent human endothelial cell growth factors from human hepatoma cells are tumor-associated proteinase inhibitors.J. Biol. Chem. 261:5378–5383.

    Google Scholar 

  18. Tsurufuji, S. 1979. How to assess inflammation in animals.Drugs Exp. Clin. Res. 5:79–84.

    Google Scholar 

  19. Maruyama, M., T. Yamamoto, H. Sumi, H. Tsushima, H. Mihara, andN. Minamino. 1986. Purification and amino acid analysis of plasma acid stable trypsin inhibitor.Enzyme 35:225–231.

    Google Scholar 

  20. Sumi, H., M. Maruyama, H. Mihara, S. Maehara, andN. Toki. 1981. Human urinary trypsin inhibitors purified by affinity chromatography on trypsin-Sepharose.Acta Haematol. Jpn. 44:146–153.

    Google Scholar 

  21. Vesterbero, O., andH. Svensson. 1966. Isoelectric fractionation, analysis, and characterization of ampholytes in natural pH gradients.Acta Chem. Scand. 20:820–827.

    Google Scholar 

  22. Noda, M., S. Shimizu, T. Tanabe, T. Takai, T. Kayano, T. Ikeda, H. Takahashi, H. Nakayama, Y. Kanaoka, N. Minamino, K. Kangawa, H. Matsuo, A. Raftery, T. Hirose, S. Inayama, H. Hayashida, T. Miyata, andS. Numa. 1984. Primary structure of electrophorus electricus sodium channel deduced from cDNA sequence.Nature 312:121–127.

    Google Scholar 

  23. Gibaldi, M., andD. Perrier. 1975. Pharmacokinetics.In Drugs and the Pharmaceutical Sciences, Vol. 1. J. Swarbrick, editor. Marcel Dekker, New York. 45–96.

    Google Scholar 

  24. Hochstrasser, K., G. Bretzel, H. Feuth, W. Hilla, andK. Lempart. 1976. Inter-α-trypsin inhibitor as precursor of the acid-stable proteinase inhibitors on human serum and urine.Hoppe-Seyler's Z. Physiol. Chem. 357:153–162.

    Google Scholar 

  25. Reisinger, P., K. Hochstkasser, G. J. Albrecht, K. Lempart, andJ. P. Salier. 1985. Human inter-α-trypsin inhibitor: Localization of the Kunitz-type domains in the N-terminal part of the molecule and their release by a trypsin-like proteinase.Biol. Chem. Hoppe-Seyler 366:479–483.

    Google Scholar 

  26. Pratt, C. W., M. W. Swaim, andS. V. Pizzo. 1989. Inflammatory cells degrade inter-α inhibitor to liberate urinary proteinase inhibitors.J. Leukocyte Biol. 45:1–9.

    Google Scholar 

  27. Yoshida, E., H. Sumi, M. Maruyama, H. Tsushima, Y. Matsuoka, M. Sugiki, andH. Mihara. 1989. Distribution of acid stable trypsin inhibitor immunoreactivity in normal and malignant human tissues.Cancer 64:860–869.

    Google Scholar 

  28. Kosugi, T., I. Takagi, O. Matsuo, H. Mihara, andO. Nishikaze. 1981. Antiplasmin activity in carrageenin-induced inflammation of rats.Int. J. Tissue React. III:173–176.

    Google Scholar 

  29. Nakagawa, H., M. Isaji, M. Hayashi, andS. Tsurufuji. 1981. Selective inhibition of collagen breakdown by proteinase inhibitors in granulation tissue in rats.J. Biochem. 89:1081–1090.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sugiki, M., Maruyama, M., Yoshida, E. et al. Acid-stable protease inhibitor in chronic phase of carrageenin-induced inflammation in rats. Inflammation 15, 281–289 (1991). https://doi.org/10.1007/BF00917313

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00917313

Keywords

Navigation